CytoDyn Announces Treatment of the First Patient in its Pivotal Phase 3 COVID-19 Trial in Brazil for Patients with Severe Symptoms

An interim analysis will be conducted 28 days following enrollment of 245 patients (40% of targeted trial patients)

VANCOUVER, Washington, Sept. 09, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the treatment of the first patient in its pivotal Phase 3 COVID-19 trial in Brazil for patients with severe symptoms. An interim analysis will be conducted 28 days following the enrollment of 245 patients, which is 40% of the total number of patients to be enrolled in the

Read more

Conventional oxygen therapy versus CPAP as a ceiling of care in ward-based patients with COVID-19: a multi-centre cohort evaluation.

ABSTRACT

Background

Continuous positive airway pressure (CPAP) therapy is commonly used for respiratory failure due to severe COVID-19 pneumonitis, including in patients deemed not likely to benefit from invasive mechanical ventilation (nIMV). Little evidence exists demonstrating superiority over conventional oxygen therapy, whilst ward-level delivery of CPAP presents practical challenges. We sought to compare clinical outcomes of oxygen therapy versus CPAP therapy in patients with COVID-19 who were nIMV.

Methods

This retrospective multi-centre cohort evaluation included patients diagnosed with COVID-19 who were nIMV, had a treatment escalation plan of ward-level care and clinical frailty scale ≤ 6. Recruitment occurred during the

Read more

Hillsborough County – Antibody Treatment Web-site in Hillsborough Expands Therapy Solutions for COVID-19 Patients

&#13
Posted August 19, 2021 | 5:49 PM&#13

A new antibody remedy web page in Hillsborough County opened today with accessibility at King Forest Park, 8008 E. Chelsea St., Tampa, FL 33610. The web-site is open up 7 times a week from 9 a.m. to 5 p.m.

The site is envisioned to handle about 300 sufferers daily making use of monoclonal antibodies that can protect against hospitalization or loss of life in substantial-hazard patients with COVID-19. Treatment method is free and can be administered no matter of regardless of whether a affected person has been vaccinated. Residents 12 many

Read more

Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Specified Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)

WILMINGTON, Del., July 23, 2021–(Business WIRE)–Incyte Company (Nasdaq:INCY) right now announced that the U.S. Foods and Drug Administration (Fda) has issued a Finish Response Letter (CRL) regarding its Biologics License Application (BLA) for retifanlimab, an intravenous PD-1 inhibitor, for the cure of grownup patients with regionally sophisticated or metastatic squamous mobile carcinoma of the anal canal (SCAC) who have progressed on, or who are intolerant of, platinum-primarily based chemotherapy.

The finish reaction letter states that the Food and drug administration cannot approve the software in its present sort. Reliable with the Oncologic Medications Advisory Committee advice on

Read more